Benzinga | Jul 31, 2020 06:40AM EDT

SVB Leerink Maintains Outperform on Veracyte, Raises Price Target to $37

SVB Leerink analyst Puneet Souda maintains Veracyte (NASDAQ:VCYT) with a Outperform and raises the price target from $32 to $37.